Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells.
- Resource Type
- Article
- Source
- Molecular Carcinogenesis; Feb2024, Vol. 63 Issue 2, p209-223, 15p
- Subject
- Language
- ISSN
- 08991987